A Monte Carlo simulation Comparing TG Lowering with Plozasiran Versus Olezarsan in Patients with FCS

Metabolism 2026

View at publisher

Authors: Nihar R. Desai, Katalin Bognar, Amanda Speller, Ashis K. Das

DOI: 10.1016/j.metabol.2026.156521

Cited by: 1

Fields of Study & Subjects

Adrenal Hormones and Disorders Pituitary Gland Disorders and Treatments Multiple Sclerosis Research Studies